Skip to content

Arvinas ARVN Change in Deferred Revenue

Change in Deferred Revenue at other companies

Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
-$1.25M+87.3%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
-$34.37M-1,536%
Monte Rosa Therapeutics, Inc. logo
Monte Rosa Therapeutics, Inc.GLUE
-$4.21M+95.0%
Immunome logo
ImmunomeIMNM
$0+100%
Arcus Biosciences logo
Arcus BiosciencesRCUS
-$17M+39.3%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
-$587K

Other financials

Income statement

See full
Revenue$15.6M-91.7%
Operating income-$63.8M-189%
Net income-$57.6M-169%
EPS (diluted)-$0.90-179%

Balance sheet

See full
Cash & equivalents$87.3M+7.8%
Total debt$8.6M-19.6%
Total equity$386.8M-41.4%
Total assets$647.5M-35.3%

Cash flow

See full
Operating cash flow-$69.2M+22.2%
CapEx$1.3M+225%
Free cash flow-$70.5M+21.1%

Valuation

See full
Market cap$518.11M-4.6%
Enterprise value$439.41M-7.1%
P/S5.8×+4.5×

Profitability

See full
Operating margin-283.8%-310pp
Net margin-247.5%-260pp
FCF margin-287.4%

Returns & leverage

See full
Return on equity-42.3%-53.5pp
Debt / equity0.0×
Current ratio5.4×+0.9×

Where this comes from

Reported directly by Arvinas in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInContractWithCustomerLiability.

The official record: Arvinas’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arvinas's change in deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arvinas's change in deferred revenue?
Arvinas (ARVN) reported change in deferred revenue of -$15.6M in Q1 2026.
How has Arvinas's change in deferred revenue changed year-over-year?
Arvinas's change in deferred revenue increased by 91.7% year-over-year, from -$188.9M to -$15.6M.
What is the long-term trend for Arvinas's change in deferred revenue?
Over 3 years (2021 to 2025), Arvinas's change in deferred revenue has grown at a -30.4% compound annual growth rate (CAGR), from $718.3M to -$242.6M.
What does change in deferred revenue mean?
Change in payments received from customers for goods/services not yet delivered — a key SaaS and subscription metric.